tirzepatide vs retatrutide 10mg — What the Research Shows Retatrutide VS. Tirzepatide: The Real

The exception: in March 2024, the FDA approved a supplemental indication for semaglutide 2.4 mg (Wegovy) to reduce the risk of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke in adults with established cardiovascular disease and either obesity or overweight (SELECT trial, Lincoff et al., New England Journal of Medicine 2023)

Physician-supervised programs provide education on: What side effects are normal vs

Presented for research literature review only Lanciotti M et al

Higher testosterone can lead to improved libido, better energy, and stronger muscle maintenance, contributing to overall sexual and physical health

(3) Stifel Obesity Market Review, July 8th

The eyecare practitioner should communicate the small possible risk of NAION, while acknowledging that a causal association with GLP-1 drugs has not been established, to other members of the care team to better inform prescribing decisions